What It Actually Means When a Micro-Cap Joins the Russell Microcap Index
FTSE Russell's June 2026 reconstitution just added a wave of new names — Star Equity, Health In Tech, AIB Data Centers, and more — to the Russell Microcap Index. Here's the mechanic behind the headline, and why it moves the stock before it moves the business.

Every June, FTSE Russell rebuilds its entire suite of U.S. stock indexes from scratch — and for a handful of micro-cap companies, getting added is one of the biggest single-day catalysts they'll see all year, even though nothing about their business changed. This year's reconstitution took effect after market close on June 26, 2026, and the additions to the Russell Microcap Index are still rolling in: Star Equity Holdings (Nasdaq: STRR), Health In Tech (Nasdaq: HIT), AIB Data Centers (NYSE American: AIB), and Mount Logan Capital all joined, while Velo3D landed spots in both the Russell 3000 and Russell Microcap indexes and popped roughly 7% on the news.
Worth flagging up front: 2026 is also the first year FTSE Russell has moved this process from an annual to a semi-annual schedule, meaning micro-cap investors now need to watch this mechanic twice a year instead of once.
How the mechanic actually works. Each year, FTSE Russell ranks roughly 4,000 U.S. stocks by total market capitalization as of a fixed "rank day" — April 30, 2026, this cycle — then sorts them into the Russell 3000, Russell 2000, Russell Microcap, and related indexes based on where they land. The Russell Microcap Index specifically captures the smallest slice of that universe: companies too small for the Russell 2000 but still part of the broader public micro-cap universe. Roughly $21.2 trillion in global assets is benchmarked to FTSE Russell indexes, and a meaningful slice of that tracks the Microcap index directly, through vehicles like the iShares Micro-Cap ETF (IWC), and indirectly through funds that use the index as a benchmark.
That benchmarking relationship is exactly why the addition moves the stock. When index funds and ETFs that track the Russell Microcap Index rebalance to reflect the new membership list, they are mechanically required to buy shares of every new addition — not because they've evaluated the company's fundamentals, but because their fund mandate requires holding the index. For a stock with a normally thin float, even a modest amount of forced, mechanical buying from passive funds can move the price meaningfully in a single session — which is the plainest explanation for Velo3D's 7% pop.
Why this matters beyond the pop. Index inclusion brings a company real, durable benefits that have nothing to do with the one-day price move: it puts the stock in front of institutional investors and fund managers who screen by index membership, it can improve trading liquidity over time as more funds hold the name, and it's a signal of legitimacy — Star Equity's CEO Jeff Eberwein called the addition a "meaningful milestone" that "expands our visibility within the institutional investment community." Companies don't lobby their way onto these indexes; they grow (or occasionally shrink) into them based on market cap alone.
The caution every reader should hold onto. The buying pressure around a reconstitution date is a flow event, not a re-rating of the business. It's temporary, mechanical, and fully priced in once the rebalancing trades settle. A stock that pops on index-inclusion day and gives it all back a week later isn't broken — it's just done digesting a one-time wave of forced buying. The real question for any of these newly-added names isn't whether they popped on the news; it's whether the underlying business justifies the market cap that got them onto the list in the first place.
This article is for informational purposes only and does not constitute investment advice.
Todd Colpron is the Managing Partner of Eliakim Capital, a private investment and strategic advisory firm that manages its own capital while working alongside select family offices and private investors to identify and support exceptional opportunities.
Important Disclosure and Disclaimer
This publication is provided solely for general educational and informational purposes. Nothing contained in this publication constitutes, or should be construed as, investment, financial, legal, accounting, or tax advice; a recommendation or endorsement of any security, issuer, transaction, or investment strategy; or personalized advice based on any reader's particular financial circumstances.
This publication does not constitute an offer to sell, a solicitation of an offer to buy, or an invitation to enter into any transaction involving securities. Any offer or sale of securities may be made only through applicable offering documents and in accordance with applicable federal and state securities laws.
The Daily MicroCap and Eliakim Capital are not registered broker-dealers and do not execute securities transactions, accept investor funds, or provide brokerage services. Unless separately and expressly disclosed, neither The Daily MicroCap nor Eliakim Capital is acting as an investment adviser to any reader, and no advisory, fiduciary, attorney-client, or other professional relationship is created by this publication.
Information contained herein may be obtained from issuers, public filings, press releases, third-party sources, or other materials believed to be reliable; however, its accuracy, completeness, timeliness, and reliability are not guaranteed, and the information may not have been independently verified. Opinions and estimates are made as of the publication date and may change without notice.
Any statements regarding anticipated events, business prospects, financial performance, valuation, market opportunities, or future results are forward-looking and inherently uncertain. Actual outcomes may differ materially due to known and unknown risks.
Microcap and emerging-company securities can be highly speculative, volatile, illiquid, and subject to substantial dilution, limited publicly available information, and the risk of a complete loss of invested capital. Readers must conduct their own independent investigation and consult appropriately licensed financial, legal, and tax professionals before making any investment decision.
Neither The Daily MicroCap nor Eliakim Capital received compensation from the issuer for preparing or distributing this article.
Past performance is not indicative of future results. No representation or warranty is made regarding any investment outcome.